Compound information
- Natural Products
- NACP154772
- Molecular Formula
- C13H19N5O10P2
- Molecular Weight
- 467.060715068 g/mol
- Structure
-
- IUPAC Name
- [[5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-(3-methyloxiran-2-yl)phosphinic acid
- InChI
- InChI=1S/C13H19N5O10P2/c1-5-13(26-5)29(21,22)28-30(23,24)25-2-6-8(19)9(20)12(27-6)18-4-17-7-10(14)15-3-16-11(7)18/h3-6,8-9,12-13,19-20H,2H2,1H3,(H,21,22)(H,23,24)(H2,14,15,16)
- InChI Key
- XLKKASKVRUMAHE-UHFFFAOYSA-N
- SMILES
- O=P(O)(OCC1OC(N2C=NC=3C(=NC=NC32)N)C(O)C1O)OP(=O)(O)C4OC4C
- CAS
- 120909-50-4
- SuperClass
- Nucleosides, nucleotides, and analogues
- Class
- Purine nucleotides
- SubClass
- Purine ribonucleotides
- Source
- CNP0330710
Warheads
- Epoxide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 4 |
Heteroatom Count | 17 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 13 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 224.9 Å2 | LogP | -3.915 |
LogS | -0.786 | LogD | -1.602 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.997 | Pgp substrate | 0.444 |
HIA | 0.922 | F20 % | 0.001 |
F30 % | 0.004 | Caco-2 | -6.236 |
MDCK | -5.999 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.448 | PPB | 33.859 |
VD | 0.704 | Fu | 0.147 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.359 |
CYP2A6 substrate | 0.324 | CYP2B6 substrate | 0.271 |
CYP2C19 inhibitor | 0.006 | CYP2C19 substrate | 0.228 |
CYP2C8 substrate | 0.323 | CYP2C9 inhibitor | 0.004 |
CYP2C9 substrate | 0.016 | CYP2D6 inhibitor | 0.072 |
CYP2D6 substrate | 0.122 | CYP2E1 substrate | 0.57 |
CYP3A4 inhibitor | 0.056 | CYP3A4 substrate | 0.011 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.897 | CL | 0.942 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 1.0 | Hepatotoxicity | 0.003 |
Mutagenicity | 0.009 | Rat Oral Acute Toxicity | 0.586 |
FDAMDD | 0.951 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.738 | Eye Corrosion | 0.001 |
Eye Irritation | 0.005 | Respiratory Toxicity | 0.2 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.337 | IGC50 | 2.368 |
LC50FM | -3.465 | LC50DM | 4.53 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.275 | NR-AR-LBD | 0.251 |
NR-AhR | 0.003 | NR-Aromatase | 0.046 |
NR-ER | 0.389 | NR-ER-LBD | 0.339 |
NR-PPAR-gamma | 0.269 | SR-ARE | 0.013 |
SR-ATAD5 | 0.327 | SR-HSE | 0.0 |
SR-MMP | 0.0 | SR-p53 | 0.067 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.